Abstract
Chondromodulating chimeric prodrugs of diacetylrhein were synthesized with an objective of potentiating its moderate anti-inflammatory effect and optimizing its hydrophilic/lipophilic balance by conjugating it with essential amino acids through a bioreversible amide linkage. In vitro release in HCl buffer (pH 1.2) showed insignificant release of diacetylrhein. However in phosphate buffer (pH 7.4), almost complete release of diacetylrhein was attained over a period of 4.5 h, following first order kinetics. The prodrug was screened extensively for therapeutic efficacy in monoiodoacetateinduced rat hyperalgesia model for levels of various markers of osteoarthritis, knee diameter and locomotor activity over a period of three months. Amongst the three prodrugs synthesized, diacetylrhein-L-tryptophan prodrug exhibited highest activity by reducing knee diameter, serum alkaline phosphatase and serum glucosaminoglycan to the baseline levels while increasing the spontaneous locomotor activity. It was found to provide maximum protection against Freund’s adjuvant arthritis with minimum ulcerogenic potential and better chondroprotection than diacetylrhein.
Keywords: Chimeric prodrugs, Diacetylrhein, Essential amino acids, IL-1 inhibitor, Monoiodoacetate-induced hyperalgesia, Osteoarthritis, Ulcerogenicity, hyaluronic acid, D-phenylalanine, L-tryptophan
Medicinal Chemistry
Title:Chondromodulating Chimeric Prodrugs of Diacetylrhein: Synthesis and Evaluation in Monoiodoacetate-induced Hyperalgesia
Volume: 9 Issue: 3
Author(s): Suneela Dhaneshwar and Dipmala Patil
Affiliation:
Keywords: Chimeric prodrugs, Diacetylrhein, Essential amino acids, IL-1 inhibitor, Monoiodoacetate-induced hyperalgesia, Osteoarthritis, Ulcerogenicity, hyaluronic acid, D-phenylalanine, L-tryptophan
Abstract: Chondromodulating chimeric prodrugs of diacetylrhein were synthesized with an objective of potentiating its moderate anti-inflammatory effect and optimizing its hydrophilic/lipophilic balance by conjugating it with essential amino acids through a bioreversible amide linkage. In vitro release in HCl buffer (pH 1.2) showed insignificant release of diacetylrhein. However in phosphate buffer (pH 7.4), almost complete release of diacetylrhein was attained over a period of 4.5 h, following first order kinetics. The prodrug was screened extensively for therapeutic efficacy in monoiodoacetateinduced rat hyperalgesia model for levels of various markers of osteoarthritis, knee diameter and locomotor activity over a period of three months. Amongst the three prodrugs synthesized, diacetylrhein-L-tryptophan prodrug exhibited highest activity by reducing knee diameter, serum alkaline phosphatase and serum glucosaminoglycan to the baseline levels while increasing the spontaneous locomotor activity. It was found to provide maximum protection against Freund’s adjuvant arthritis with minimum ulcerogenic potential and better chondroprotection than diacetylrhein.
Export Options
About this article
Cite this article as:
Dhaneshwar Suneela and Patil Dipmala, Chondromodulating Chimeric Prodrugs of Diacetylrhein: Synthesis and Evaluation in Monoiodoacetate-induced Hyperalgesia, Medicinal Chemistry 2013; 9 (3) . https://dx.doi.org/10.2174/1573406411309030015
DOI https://dx.doi.org/10.2174/1573406411309030015 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacotherapy of Schizophrenia: The Past, Present and Future
Current Drug Therapy Phenolic Compounds in Prevention and Treatment of Skin Cancers: A Review
Current Medicinal Chemistry Bronchoalveolar Lavage in Systemic Sclerosis Patients: A Systematic Review
Current Rheumatology Reviews Pentapeptides as Minimal Functional Units in Cell Biology and Immunology
Current Protein & Peptide Science Cardiovascular Pharmacogenetics of Anti-Thrombotic Agents and Non-Steroidal Anti-Inflammatory Drugs
Current Molecular Medicine Neurodegeneration and Neuroprotection in Multiple Sclerosis
Current Pharmaceutical Design Advanced Tools of Regenerative Medicine for Neurodegenerative Diseases
Recent Patents on Regenerative Medicine Anti- SARS-CoV-2 IgG and IgM Levels in Iraqi General Population
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Developing Specific Therapeutic Strategies for Transfusion-Related Acute Lung Injury. An Overview of Potentially Useful Animal Models
Cardiovascular & Hematological Agents in Medicinal Chemistry The Common Mycobacterial Antigens and their Importance in the Treatment of Disease
Current Pharmaceutical Design Targeting Conserved Pathways: Mitochondrial Dysfunction and Beyond
Current Neurovascular Research Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases
Current Medicinal Chemistry Choice of Treatment with Antidepressants: Influencing Factors
Current Pharmaceutical Design Epidemiology, Pathophysiology, and Pharmacological Status of Asthma
Current Respiratory Medicine Reviews Therapeutic Option of Plasmid-DNA Based Gene Transfer
Current Topics in Medicinal Chemistry An Effective Vaccination Approach Augments Anti-HIV Systemic and Vaginal Immunity in Mice with Decreased HIV-1 Susceptible α4β7high CD4+ T Cells
Current HIV Research Application of Cytokines of the Bone Morphogenetic Protein (BMP) Family in Spinal Fusion - Effects on the Bone, Intervertebral Disc and Mesenchymal Stromal Cells
Current Stem Cell Research & Therapy Search of QSAR Models for Predicting the Antiprotozoal Activity and Cytotoxicity In Vitro of a Group of Pentamidine Analogous Compounds
Letters in Drug Design & Discovery Mechanism of CNS Drugs and their Combinations for Alzheimers Disease
Central Nervous System Agents in Medicinal Chemistry Advancements in Treatment Options of Women Infertility
Current Women`s Health Reviews